Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India

• প্রধান লেখক: Anil Kamat (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2018-03-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: Acute lymphoblastic leukemia (ALL) is a cancer of lymphoid progenitor cells with highest incidence among children aged 2-3 years. Pegaspargase, the PEGylated form of L-asparaginase (PEG-ASP) is a component of multidrug regimens used in the management of ALL. Data on experience of PEG-ASP...